Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,198,500 | 169,180 | 156,970 | 271,000 | N/A |
| Marketable Securities | 2,877,000 | 441,390 | 324,950 | 401,000 | N/A |
| Receivables | 8,557,500 | 914,500 | 974,010 | 787,100 | N/A |
| Inventories | 6,963,000 | 408,910 | 431,150 | 410,000 | N/A |
| Other current assets | 0 | 0 | 10 | 0 | 0 |
| TOTAL | $19,596,000 | $1,933,980 | $1,887,090 | $1,869,100 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 20,746,500 | 1,857,250 | 1,856,280 | 1,826,900 | N/A |
| Investments And Advances | 315,000 | 38,210 | 45,610 | 41,800 | 0 |
| Other Non-Current Assets | 355,500 | 38,670 | 37,860 | 27,900 | 0 |
| TOTAL | $21,417,000 | $1,934,130 | $1,939,750 | $1,896,600 | $N/A |
| Total Assets | $41,013,000 | $3,868,120 | $3,826,850 | $3,765,700 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,152,000 | 87,460 | 134,250 | 489,200 | 0 |
| Accrued Expenses | 1,242,000 | 0 | 0 | 0 | N/A |
| Other current liabilities | 4,120,500 | 426,430 | 443,890 | 33,500 | N/A |
| TOTAL | $8,229,000 | $800,300 | $842,850 | $839,100 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,752,500 | 265,550 | 162,470 | 238,400 | N/A |
| aiOther Non-Current Liabilities | 3,073,500 | 73,700 | 70,730 | 86,200 | 0 |
| TOTAL | $5,826,000 | $339,250 | $233,200 | $324,600 | $N/A |
| Total Liabilities | $14,055,000 | $1,139,570 | $1,076,070 | $1,163,700 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1,131,000 | 113,290 | 129,080 | 135,200 | N/A |
| Retained earnings | 0 | 2,197,580 | 2,165,740 | 1,987,900 | N/A |
| Other shareholders' equity | 21,979,500 | 34,150 | 18,950 | 21,100 | 0 |
| TOTAL | $26,958,000 | $2,728,550 | $2,750,770 | $2,602,000 | $N/A |
| Total Liabilities And Equity | $41,013,000 | $3,868,120 | $3,826,840 | $3,765,700 | $0 |